Azaindoles useful as inhibitors of JAK and other protein kinases

Details for Australian Patent Application No. 2005228904 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Court, John; Robinson, Daniel; Charrier, Jean-Damien; Fraysse, Damien; Mortimore, Michael; Lauffer, David; Bethiel, Randy; Farmer, Luc; Harrington, Edmund; Come, Jon; Green, Jeremy; Everitt, Simon; Binch, Hayley; Salituro, Francesco; Pierard, Francoise; Aronov, Alex; Boyall, Dean

Agent Cullens

Pub. Number AU-B-2005228904

PCT Pub. Number WO2005/095400

Priority 60/557,503 30.03.04 US; 60/625,599 05.11.04 US

Filing date 30 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 10 May 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/095400 Priority application(s): WO2005/095400

10 May 2012 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to read Court, John Robinson, Daniel Charrier, Jean-Damien Fraysse, Damien Mortimore, Michael Lauffer, David Bethiel, Randy Farmer, Luc Harrington, Edmund Come, Jon Green, Jeremy Everitt, Simon Binch, Hayley Salituro, Francesco Pierard, Francoise Aronov, Alex Boyall, Dean Wang, Jian Pinder, Joanne Wang, Tiansheng Pierce, Albert. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 400

10 May 2012 Application Accepted

  Published as AU-B-2005228904

17 May 2012 Corrigenda

  Applications Accepted - Name Index Under the name Vertex Pharmaceuticals Incorporated, Application No. 2005228904, under INID (72) add co-inventors Wang, Jian; Pinder, Joanne; Wang, Tianshen and Pierce, Albert

2 August 2012 Corrigenda

  Applications Accepted - Name Index Under the name Vertex Pharmaceuticals Incorporated, Application No. 2005228904, under INID (72) correct the co-inventor to Wang, Tiansheng Corrigenda

16 August 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 27 Jul 2012 . Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000

30 August 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Court, John; Robinson, Daniel; Charrier, Jean-Damien; Fraysse, Damien; Mortimore, Michael; Lauffer, David; Bethiel, Randy; Farmer, Luc; Harrington, Edmund; Come, Jon; Green, Jeremy; Everitt, Simon; Binch, Hayley; Salituro, Francesco; Pierard, Francoise; Aronov, Alex; Boyall, Dean; Wang, Jian; Pinder, Joanne; Wang, Tiansheng and Pierce, Albert

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005228905-Novel thiazolopyrazoles and methods of their use

2005228903-Infrared reflective wall paint